Long-Term Results of Concomitant Boost Radiation plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: a Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)

Ítems similars

• Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024
  per: Rosenthal, David I., et al.
  Publicat: (2009)
• Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
  per: Machtay, Mitchell, et al.
  Publicat: (2008)
• Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
  per: Ang, K. Kian, et al.
  Publicat: (2014)
• Final Results of Local-Regional Control and Late Toxicity of RTOG 90-03; A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head And Neck Cancer
  per: Beitler, Jonathan J, et al.
  Publicat: (2014)
• The Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group (RTOG) Trials
  per: Dilling, Thomas J., et al.
  Publicat: (2011)